Healthcare Professionals - North America
 
  
Elekta is an international medical-technology Group. Our treatment systems and software solutions are used at over 4,500 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and therefore both maximize clinical and cost-effectiveness whilst minimizing trauma for patients.

CUSTOMER IDEAS:
Elekta welcomes your comments on our products. With encouragement from your ideas we can look forward to creating new and enhanced clinical solutions - click here


HIPAA:
Statement of Compliance to the Health Insurance Portability and Accountability Act - click

Canadian flag

LATEST PRESS RELEASES:
26-08-2008: Elekta Receives CE Mark Clearance for 'Everyday Radiation Therapy' Accelerator, Elekta Compact
22-08-2008: CMS, INC., An Elekta Company, Receives FDA 510(k) Clearance for ATLAS-BASED AUTOSEGMENTATION SOFTWARE
11-08-2008: Skagit Valley Hospital Regional Cancer Care Center Enhances Patient Care with Elekta Axesse
30-07-2008: Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
25-07-2008: Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting

NOTE:
This website is not intended as a substitute for professional medical advice and does not provide advice on treatments or conditions for individual patients. All health and treatment decisions must be made in consultation with your physician(s), utilizing your specific medical information. The links set out on this web site are provided for your convenience only. Elekta does not endorse the information contained on these linked web sites or individual(s) / companies / institutions operating these web site(s)

Highest accuracy for the localization and treatment of targets deep within the brain

Revolutionary design expands the treatment reach, offering a wider range of treatable anatomical structure

Eliminating external interference to give clear insight into brain function

Rapid beam start-up and excellent dose accuracy during the delivery of low dose sequential IMRT fields

Inspiring clinical confidence to reduce margins, increase dose, spare healthy tissues and improve outcomes with IGRT

Treating cancer more effectively means fewer treatments, fewer hospital visits and less physical, mental and emotional strain for your patients

  Sitemap  
 © Copyright 2008 Elekta AB (publ). All rights reserved.